NCI-H146 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The NCI-H146 cell line was derived by A.F. Gazdar and associates in 1979 from the pleural fluid of a patient with small cell cancer of the lung. The bone marrow specimen was taken prior to therapy. |
|---|---|
| Organism | Human |
| Tissue | Lung |
| Disease | Small cell carcinoma |
| Metastatic site | Bone marrow |
| Synonyms | H146, H-146, NCIH146 |
Characteristics
| Age | 59 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Aggregates in suspension |
Regulatory Data
| Citation | NCI-H146 (Cytion catalog number 300182) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1473 |
Biomolecular Data
| Receptors expressed | Insulin-like growth factor II receptor (IGF II) |
|---|---|
| Protein expression | The cells stain positively for vimentin and keratin, but are negative for neurofilament triplet protein. |
| Antigen expression | The line expresses elevated levels of four biochemical markers: neuron specific enolase, brain isoenzyme of creatine kinase, L-DOPA decarboxylase and bombesin-like immunoreactivity |
| Isoenzymes | G6PD, B, PGM1, 1-2, PGM3, 1-2, ES-D, 1, Me-2, 2, AK-1, 1, GLO-1, 1, Phenotype Frequency Product = 0.0009 |
| Tumorigenic | Forms transplantable tumors in nude mice which histologically resemble tumor cells from the original biopsy specimen |
| Products | The cells produce relatively high amounts of c-myc mRNA, but c-myc DNA sequences are not amplified. The cells do not express vasopressin, oxytocin or gastrin releasing peptide. |
| Ploidy status | Aneuploid |
| MSI-status | Stable (MSS) |
| Karyotype | This is a near triploid human cell line. The modal chromosome number is 68, but cells with 66, 70 and 71 chromosomes also occurred frequently. The x chromosomes were paired, and no Y chromosome was detected in QM stained preparations. |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% heat-inactivated FBS |
| Subculturing | The cells should be subcultured by transferring part of the suspension into fresh new cell culture flasks prefilled with fresh medium. Alternatively, the clusters may be collected by centrifugation and resuspended in fresh medium. |
| Seeding density | 1 to 2 x 105 cells/ml |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing allow the cells to recover from the freezing process for at least 24 to 48 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300182-110725 | Certificate of Analysis | 18. Aug. 2025 | 300182 |
| 300182-240425 | Certificate of Analysis | 23. May. 2025 | 300182 |
-
Related products
Related products